Ark

Ark launches stomach cancer blood test for early stage stomach cancer detection
By Dean Koh | 11:19 pm | December 05, 2018
Ark, a Singapore-based medtech enterprise focused on early cancer detection, has raised a record US$40 million in Series A funding.